To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure
- PMID: 37286178
- DOI: 10.1055/a-2107-0576
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure
Abstract
Variceal bleeding is a consequence of severe portal hypertension in patients with liver cirrhosis. Although the rate of bleeding has decreased over time, variceal bleeding in the presence of acute-on-chronic liver failure (ACLF) carries a high risk of treatment failure and short-term mortality. Treatment and/or removal of precipitating events (mainly bacterial infection and alcoholic hepatitis) and decrease of portal pressure may improve outcome of patients with acute decompensation or ACLF. Transjugular intrahepatic portosystemic shunts (TIPSs), especially in the preemptive situation, have been found to efficiently control bleeding, prevent rebleeding, and reduce short-term mortality. Therefore, TIPS placement should be considered as an option in the management of ACLF patients with variceal bleeding.
Thieme. All rights reserved.
Conflict of interest statement
J.T. has received speaking and/or consulting fees from Gore, Alexion, MSD, Grifols, Versantis, and CSL Behring. W.L. has received consultancy fees from CSL Behring, Cook Medical, Boston-Scientific, and Norgine.
Similar articles
-
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.J Hepatol. 2020 Nov;73(5):1082-1091. doi: 10.1016/j.jhep.2020.04.024. Epub 2020 Apr 24. J Hepatol. 2020. PMID: 32339602
-
Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding.J Hepatol. 2021 Jan;74(1):66-79. doi: 10.1016/j.jhep.2020.06.010. Epub 2020 Jun 16. J Hepatol. 2021. PMID: 32561318
-
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD001023. doi: 10.1002/14651858.CD001023.pub3. Cochrane Database Syst Rev. 2018. PMID: 30378107 Free PMC article.
-
Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions.World J Gastroenterol. 2021 Nov 28;27(44):7612-7624. doi: 10.3748/wjg.v27.i44.7612. World J Gastroenterol. 2021. PMID: 34908802 Free PMC article. Review.
-
Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding.Radiology. 2005 Jul;236(1):360-7. doi: 10.1148/radiol.2361040530. Epub 2005 Jun 13. Radiology. 2005. PMID: 15955858
Cited by
-
Should transjugular intrahepatic portosystemic shunt be first-line therapy for preventing esophageal variceal rebleeding? A meta-analysis of clinical outcomes.Proc (Bayl Univ Med Cent). 2025 Jun 11;38(5):627-636. doi: 10.1080/08998280.2025.2514978. eCollection 2025. Proc (Bayl Univ Med Cent). 2025. PMID: 40821462 Free PMC article. Review.
-
Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting.J Clin Med. 2024 Jan 21;13(2):600. doi: 10.3390/jcm13020600. J Clin Med. 2024. PMID: 38276106 Free PMC article. Review.
-
Acute and non-acute decompensation of liver cirrhosis (47/130).Liver Int. 2025 Mar;45(3):e15861. doi: 10.1111/liv.15861. Epub 2024 Mar 1. Liver Int. 2025. PMID: 38426268 Free PMC article. Review.
MeSH terms
Grants and funding
- DECISION (project ID: 847949)/European Union's Horizon 2020 research and innovation program
- GALAXY (project ID: 668031)/European Union's Horizon 2020 research and innovation program
- IHMCSA (project ID: 964590)/European Union's Horizon 2020 research and innovation program
- LIVERHOPE (project ID: 731875)/European Union's Horizon 2020 research and innovation program
- MICROB-PREDICT (project ID: 825694)/European Union's Horizon 2020 research and innovation program
LinkOut - more resources
Full Text Sources